CCR2 inhibition reduces tumor myeloid cells and unmasks a checkpoint inhibitor effect to slow progression of resistant murine gliomas.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: 2019-12-26
Affiliations: 6
Go to article